Botanix Pharmaceuticals Limited (BXPHF)
OTCMKTS · Delayed Price · Currency is USD
0.0883
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of $161.27 million as of February 12, 2026. Its market cap has decreased by -67.43% in one year.
Market Cap
161.27M
Enterprise Value
115.89M
Revenue
3.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 9.31M to 161.27M, an increase of 1,632.71%. That is a compound annual growth rate of 34.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 161.27M | -9.02% |
| Dec 31, 2025 | 177.24M | -63.78% |
| Dec 31, 2024 | 489.30M | 144.19% |
| Dec 29, 2023 | 200.38M | 368.44% |
| Dec 30, 2022 | 42.78M | 7.95% |
| Dec 31, 2021 | 39.62M | -57.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.62M |
| CytoDyn | 317.38M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 113.23M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |